What changes for you if the wording is not exact?
The commentary matches the change in wording on the recent announcement of BLA acceptance and PDUFA dates.
Mesoblast anticipates a decision on or before the FDA’s Prescription Drug User Fee Act (PDUFA) goal
date of January 7, 2025
Prior to that in 2023 we just got a date, and the first one in 2020 was a date with priority review.
Silviu will be sweating on an decision prior to the AGM
Reg
What changes for you if the wording is not exact?The commentary...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
0.023(2.12%) |
Mkt cap ! $1.218B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.06 | $1.332M | 1.240M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 13369 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 76024 | 8 |
View Market Depth
| Last trade - 12.48pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |